ESC Premium Access

Novel biomarker-based risk scores for better stratification of stroke and major bleeding risk in AF patients and OAC therapy optimization.


Congress Presentation

About the speaker

Associate Professor Ziad Hijazi

Uppsala University, Uppsala (Sweden)
4 presentations
0 follower

2 more presentations in this session

Bleeding risk as one of major hurdles in stroke prevention therapy prescription.

Speaker: Professor C. Granger (Durham, US)


How do we assess anticoagulant activity in emergency situations in NOAC treated AF patients?

Speaker: Professor P. Kamphuisen (Hilversum, NL)


Access the full session

Biomarker-based approaches for improved atrial fibrillation management

Speakers: Associate Professor Z. Hijazi, Professor C. Granger, Professor P. Kamphuisen

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb